|
2023
|
Invention
|
Treatment regimens.
The invention relates to 5-fluoro-2′-deoxyuridine-5′-O-[1-naphthyl (benzoxy-... |
|
|
Invention
|
Formulations of phosphoramidate derivatives of nucleoside drugs.
This invention relates to pharm... |
|
|
Invention
|
Synthesis of nucleoside derivative nuc-3373. This invention relates to a novel process for the pr... |
|
|
Invention
|
Cancer treatment with nuc-7738. The invention provides NUC-7738 (3'-deoxyadenosine-5'-O-[phenyl(b... |
|
|
Invention
|
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer. mycop... |
|
2022
|
Invention
|
Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds.
The present inventi... |
|
|
Invention
|
Synthesis of phosphate derivatives. The present invention is a process for the preparation of cer... |
|
|
Invention
|
Cancer treatments based on gemcitabine prodrugs.
Disclosed is NUC-1031 (gemcitabine-[phenyl-benz... |
|
|
Invention
|
Cancer treatments.
Provided are medical uses and methods for targeting cancer stem cells employi... |
|
|
Invention
|
Combination therapy.
This invention relates to a combination of gemcitabine-[phenyl-benzoxy-L-al... |
|
|
Invention
|
Combination therapy for cancer.
This invention relates to a combination of gemcitabine-[phenyl-b... |
|
|
Invention
|
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compo... |
|
2021
|
Invention
|
Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds.
The present invent... |
|
|
Invention
|
Formulation comprising a gemcitabine-prodrug. This invention relates to pharmaceutical formulatio... |
|
|
Invention
|
Process for preparing nucleoside prodrugs.
A process for preparing phosphoramidates of nucleosid... |
|
|
Invention
|
Formulations of phosphoramidate derivatives of nucleoside drugs. This invention relates to pharma... |
|
|
Invention
|
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer. Mycop... |
|
|
Invention
|
Phosphoramidate nucleoside derivatives as anticancer agents.
This invention relates to derivativ... |
|
2020
|
Invention
|
Cancer treatments based on gemcitabine prodrugs.
Disclosed is NUC-1031 (gemcitabine[phenyl-benzo... |
|
|
Invention
|
Diastereoselective synthesis of phosphate derivatives. The present invention provides a method fo... |
|
|
Invention
|
Gemcitabine prodrugs. L-alaninyl)]-phosphate when present as a single phosphate diastereoisomer a... |
|
|
Invention
|
Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds. The present inventi... |
|
2019
|
Invention
|
Synthesis of 8-chloroadenosine derivatives including nuc-9701. The present invention generally re... |
|
2018
|
Invention
|
Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds. The present inventio... |
|
|
Invention
|
Floxuridine synthesis. The present invention relates to a process for the preparation of floxurid... |
|
|
Invention
|
Combination therapy.
This invention relates to a combination of 2′-Deoxy-2′,2′-difluoro-D-cytidi... |
|
|
Invention
|
Treatment regimens. The invention relates to 5-fluoro-2'-deoxyuridine-5'-O-[1-naphthyl (benzoxy-L... |
|
|
Invention
|
Combination therapy. This invention relates to a combination of 2'-Deoxy-2',2'-difluoro-D-cytidin... |
|
|
Invention
|
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer. Phosp... |
|
|
Invention
|
Synthesis of 3′-deoxyadenosine-5′-o-[phenyl(benzyloxy-l-alaninyl)]phosphate (nuc-738). The presen... |
|
|
Invention
|
Synthesis of substantially diastereomerically pure phosphate protides. The present invention gene... |
|
|
G/S
|
Pharmaceutical and veterinary preparations and substances for the prevention, diagnosis and treat... |
|
|
G/S
|
Pharmaceutical and veterinary preparations and substances for use in relation to the prevention, ... |
|
|
G/S
|
Pharmaceutical and veterinary preparations and substances;
pharmaceutical products; diagnostic p... |
|
2017
|
Invention
|
Phosphoramidate nucleoside derivatives as anticancer agents. This invention relates to derivative... |
|
|
Invention
|
Cancer treatments. Provided are medical uses and methods for targeting cancer stem cells employin... |
|
|
Invention
|
Adenosine derivatives for use in the treatment of cancer.
The present invention relates to chemi... |
|
2016
|
Invention
|
Crystalline form of gemcitabine. This invention relates to a crystalline form of gemcitabine-[phe... |
|
2015
|
Invention
|
Combination therapy.
This invention relates to a combination of gemcitabine-[phenyl-(benzoxy-L-a... |
|
2006
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, autoimmune diseases and central nervous ... |
|
|
G/S
|
Chemicals used in industry and science. Pharmaceutical and veterinary preparations. Scientific an... |
|
2005
|
Invention
|
Phosphoramidate compounds and methods of use. Phosphoramidate derivatives of nucleotides and thei... |
